Screener
Amylyx Pharmaceuticals, Inc. AMLX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (45,693) | (42,857) | (89,472) | (80,660) |
| Other income, net: | ||||
| Interest income | 2,323 | 1,960 | 4,893 | 4,191 |
| Other expense, net | (53) | (546) | (128) | (881) |
| Total other income, net | 2,270 | 1,414 | 4,765 | 3,310 |
| Net loss | $(43,423) | $(41,443) | $(84,707) | $(77,350) |
| Net loss per share — basic and diluted | $(0.39) | $(0.46) | $(0.76) | $(0.88) |
| Weighted-average shares used in computing net loss per share — basic and diluted | 111,196,883 | 89,138,568 | 110,881,872 | 87,427,345 |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s other income, net (note 6)?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported other income, net (note 6) of -$53K in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s other income, net (note 6) changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s other income, net (note 6) increased by 90.3% year-over-year, from -$546K to -$53K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude